Image

Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer Survivors

Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer Survivors

Recruiting
18-39 years
All
Phase N/A

Powered by AI

Overview

This study assesses how personal relationships (such as friendships, family relationships, or romantic partners) influence the physical activity (exercise) and well-being of young adult cancer survivors. Researchers also hope to learn how social relationships change after a cancer diagnosis, and how these changes might impact important health behaviors. The information provided may help researchers learn more about better ways to support young cancer patients in the future through interventions that help maintain good social relationships and health levels of physical activity.

Description

PRIMARY OBJECTIVES:

I. Characterize the trajectories of social health in young adult (YA) cancer patients.

II. Investigate the longitudinal associations between social health and activity behaviors in YA cancer patients.

III. Explore the effects of sociodemographic and clinical characteristics on the relationship between social health, activity behaviors, and quality of life.

OUTLINE

Patients complete surveys over 40 minutes and wear an actigraph GT3X-BT accelerometer continuously for 7 days at baseline, 3, 6, and 12 months.

Eligibility

Inclusion Criteria:

  • Diagnosed and/or treated with cancer between ages 18-39 at USC hospitals.
  • Cancer types prototypical for adolescents and young adults (AYAs) and cancer stages I-III; select patients with stage IV disease may be eligible, with approval by the principal investigator (PI) and in consultation with the treating clinician.
  • Must be within three months of a de novo cancer diagnosis at recruitment and on/indicated for curative therapy (any modality). Patients may continue on adjuvant therapy throughout duration of the study.
  • Patients must have anticipated survival of \>1-year at time of diagnosis.

Exclusion Criteria:

  • Diagnosis of blood malignancies such as leukemias (these cancers have divergent treatment patterns of longer duration than other cancers and are more commonly pediatric cancers). Some early stage lymphomas with favorable prognoses may be eligible, with approval by the PI and in consultation with the treating clinician.
  • Primary language other than English or Spanish.
  • Inability to complete a survey and/or wear an accelerometer either per the patient or in consultation with the clinician's judgment.

Study details
    Anatomic Stage I Breast Cancer AJCC v8
    Anatomic Stage IA Breast Cancer AJCC v8
    Anatomic Stage IB Breast Cancer AJCC v8
    Anatomic Stage II Breast Cancer AJCC v8
    Anatomic Stage IIA Breast Cancer AJCC v8
    Anatomic Stage IIB Breast Cancer AJCC v8
    Anatomic Stage III Breast Cancer AJCC v8
    Anatomic Stage IIIA Breast Cancer AJCC v8
    Anatomic Stage IIIB Breast Cancer AJCC v8
    Anatomic Stage IIIC Breast Cancer AJCC v8
    Central Nervous System Neoplasm
    Clinical Stage I Cutaneous Melanoma AJCC v8
    Clinical Stage IA Cutaneous Melanoma AJCC v8
    Clinical Stage IB Cutaneous Melanoma AJCC v8
    Clinical Stage II Cutaneous Melanoma AJCC v8
    Clinical Stage IIA Cutaneous Melanoma AJCC v8
    Clinical Stage IIB Cutaneous Melanoma AJCC v8
    Clinical Stage IIC Cutaneous Melanoma AJCC v8
    Clinical Stage III Cutaneous Melanoma AJCC v8
    Hodgkin Lymphoma
    Malignant Bone Neoplasm
    Malignant Brain Neoplasm
    Malignant Solid Neoplasm
    Malignant Testicular Neoplasm
    Non-Hodgkin Lymphoma
    Pathologic Stage I Cutaneous Melanoma AJCC v8
    Pathologic Stage IA Cutaneous Melanoma AJCC v8
    Pathologic Stage IB Cutaneous Melanoma AJCC v8
    Pathologic Stage II Cutaneous Melanoma AJCC v8
    Pathologic Stage IIA Cutaneous Melanoma AJCC v8
    Pathologic Stage IIB Cutaneous Melanoma AJCC v8
    Pathologic Stage IIC Cutaneous Melanoma AJCC v8
    Pathologic Stage III Cutaneous Melanoma AJCC v8
    Pathologic Stage IIIA Cutaneous Melanoma AJCC v8
    Pathologic Stage IIIB Cutaneous Melanoma AJCC v8
    Pathologic Stage IIIC Cutaneous Melanoma AJCC v8
    Pathologic Stage IIID Cutaneous Melanoma AJCC v8
    Prognostic Stage I Breast Cancer AJCC v8
    Prognostic Stage IA Breast Cancer AJCC v8
    Prognostic Stage IB Breast Cancer AJCC v8
    Prognostic Stage II Breast Cancer AJCC v8
    Prognostic Stage IIA Breast Cancer AJCC v8
    Prognostic Stage IIB Breast Cancer AJCC v8
    Prognostic Stage III Breast Cancer AJCC v8
    Prognostic Stage IIIA Breast Cancer AJCC v8
    Prognostic Stage IIIB Breast Cancer AJCC v8
    Prognostic Stage IIIC Breast Cancer AJCC v8
    Stage I Cervical Cancer AJCC v8
    Stage I Colorectal Cancer AJCC v8
    Stage I Differentiated Thyroid Gland Carcinoma AJCC v8
    Stage I Ovarian Cancer AJCC v8
    Stage I Thyroid Gland Medullary Carcinoma AJCC v8
    Stage I Uterine Corpus Cancer AJCC v8
    Stage IA Cervical Cancer AJCC v8
    Stage IA Ovarian Cancer AJCC v8
    Stage IA Uterine Corpus Cancer AJCC v8
    Stage IA1 Cervical Cancer AJCC v8
    Stage IA2 Cervical Cancer AJCC v8
    Stage IB Cervical Cancer AJCC v8
    Stage IB Ovarian Cancer AJCC v8
    Stage IB Uterine Corpus Cancer AJCC v8
    Stage IB1 Cervical Cancer AJCC v8
    Stage IB2 Cervical Cancer AJCC v8
    Stage IC Ovarian Cancer AJCC v8
    Stage II Cervical Cancer AJCC v8
    Stage II Colorectal Cancer AJCC v8
    Stage II Differentiated Thyroid Gland Carcinoma AJCC v8
    Stage II Ovarian Cancer AJCC v8
    Stage II Thyroid Gland Medullary Carcinoma AJCC v8
    Stage II Uterine Corpus Cancer AJCC v8
    Stage IIA Cervical Cancer AJCC v8
    Stage IIA Colorectal Cancer AJCC v8
    Stage IIA Ovarian Cancer AJCC v8
    Stage IIA1 Cervical Cancer AJCC v8
    Stage IIA2 Cervical Cancer AJCC v8
    Stage IIB Cervical Cancer AJCC v8
    Stage IIB Colorectal Cancer AJCC v8
    Stage IIB Ovarian Cancer AJCC v8
    Stage IIC Colorectal Cancer AJCC v8
    Stage III Cervical Cancer AJCC v8
    Stage III Colorectal Cancer AJCC v8
    Stage III Differentiated Thyroid Gland Carcinoma AJCC v8
    Stage III Ovarian Cancer AJCC v8
    Stage III Thyroid Gland Medullary Carcinoma AJCC v8
    Stage III Uterine Corpus Cancer AJCC v8
    Stage IIIA Cervical Cancer AJCC v8
    Stage IIIA Colorectal Cancer AJCC v8
    Stage IIIA Ovarian Cancer AJCC v8
    Stage IIIA Uterine Corpus Cancer AJCC v8
    Stage IIIA1 Ovarian Cancer AJCC v8
    Stage IIIA2 Ovarian Cancer AJCC v8
    Stage IIIB Cervical Cancer AJCC v8
    Stage IIIB Colorectal Cancer AJCC v8
    Stage IIIB Ovarian Cancer AJCC v8
    Stage IIIB Uterine Corpus Cancer AJCC v8
    Stage IIIC Colorectal Cancer AJCC v8
    Stage IIIC Ovarian Cancer AJCC v8
    Stage IIIC Uterine Corpus Cancer AJCC v8
    Stage IIIC1 Uterine Corpus Cancer AJCC v8
    Stage IIIC2 Uterine Corpus Cancer AJCC v8

NCT07259304

University of Southern California

31 January 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.